Assignee
HARROW IP LLC
US·14 granted patents·18 pending applications·6 citations·filing 2014–2025
Top patents by PatentIndex Score
32 records- 0183US10561607B2Pharmaceutical compositions comprising gels and methods for fabricating thereofHARROW IP LLC·Filed 2016·Granted Feb 18, 2020·2 cites·8 claims
- 0280US12478639B2Ocular lubricant formulationsHARROW IP LLC·Filed 2024·Granted Nov 25, 2025·0 cites·7 claims
- 0380US2026041708A1Ocular lubricant formulationsHARROW IP LLC·Filed 2025·Application pending·0 cites
- 0478US11045432B2Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofHARROW IP LLC·Filed 2016·Granted Jun 29, 2021·1 cites·7 claims
- 0578US10993921B2Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofHARROW IP LLC·Filed 2014·Granted May 4, 2021·1 cites·5 claims
- 0677US10660891B2Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereofHARROW IP LLC·Filed 2019·Granted May 26, 2020·1 cites·27 claims
- 0775US2024423970A1Extended-release pharmaceutical compositions for treating eye conditionsHARROW IP LLC·Filed 2024·Application pending·0 cites
- 0874US10695351B2Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereofHARROW IP LLC·Filed 2019·Granted Jun 30, 2020·1 cites·14 claims
- 0971US11918603B2Ocular lubricant formulationsHARROW IP LLC·Filed 2019·Granted Mar 5, 2024·0 cites·22 claims
- 1069US2021275471A1Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofHARROW IP LLC·Filed 2021·Application pending·0 cites
- 1166US2023277521A1Extended-release pharmaceutical compositions for treating eye conditionsHARROW IP LLC·Filed 2022·Application pending·0 cites
- 1265US11338018B2Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereofHARROW IP LLC·Filed 2019·Granted May 24, 2022·0 cites·4 claims
- 1361US12594351B2Methods for increasing shelf-life of ophthalmic pharmaceutical compositionsHARROW IP LLC·Filed 2022·Granted Apr 7, 2026·0 cites·13 claims
- 1461US2023277694A1Ophthalmic dye composition and method for administering sameHARROW IP LLC·Filed 2023·Application pending·0 cites
- 1561US2023181630A1Packaged compositions comprising hypochlorous acid and menthol and methods of making thereofHARROW IP LLC·Filed 2022·Application pending·0 cites
- 1660US12443276B2Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote serverHARROW IP LLC·Filed 2024·Granted Oct 14, 2025·0 cites·20 claims
- 1760US11534481B2Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereofHARROW IP LLC·Filed 2020·Granted Dec 27, 2022·0 cites·9 claims
- 1860US2026083746A1Reduced dosing regimens for glaucoma treatmentHARROW IP LLC·Filed 2025·Application pending·0 cites
- 1958US2025186415A1Extended-release pharmaceutical compositions for treating eye conditionsHARROW IP LLC·Filed 2022·Application pending·0 cites
- 2057US2023181625A1Method and composition for treating infectious conjunctivitisHARROW IP LLC·Filed 2021·Application pending·0 cites
- 2157US2024058320A1Mydriatic compositions and methods for fabricating thereofHARROW IP LLC·Filed 2021·Application pending·0 cites
- 2256US11185546B2Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereofHARROW IP LLC·Filed 2020·Granted Nov 30, 2021·0 cites·13 claims
- 2353US2023302032A1Antibacterial compositions and methods for fabricating thereofHARROW IP LLC·Filed 2021·Application pending·0 cites
- 2453US2021346318A1Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofHARROW IP LLC·Filed 2021·Application pending·0 cites
- 2550US12045386B2Methods and system for remotely capturing media via a user interface bidirectionally linked to a remote serverHARROW IP LLC·Filed 2022·Granted Jul 23, 2024·0 cites·15 claims
- 2650US11266615B2Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereofHARROW IP LLC·Filed 2020·Granted Mar 8, 2022·0 cites·20 claims
- 2750US2021069237A1Pharmaceutical compositions comprising heparinoids and methods for preparing thereofHARROW IP LLC·Filed 2020·Application pending·0 cites
- 2849US2020352938A1Pharmaceutical compositions for treating presbyopia and methods for fabricating thereofHARROW IP LLC·Filed 2020·Application pending·0 cites
- 2948US2020155450A1Pharmaceutical compositions comprising gels and methods for fabricating thereofHARROW IP LLC·Filed 2020·Application pending·0 cites
- 3046US2022101386A1Methods and system for measuring interaction between a user interface and remote serverHARROW IP LLC·Filed 2021·Application pending·0 cites
- 3145US2021398624A1Systems and methods for automated intake of patient dataHARROW IP LLC·Filed 2021·Application pending·0 cites
- 3241US2021398633A1Systems and methods for transacting prescriptions using a mobile deviceHARROW IP LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HARROW IP LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →